BDBM200012 US9234000, 3::US9512065, N-[(R)-1-[(S)-1-(4-aminomethyl-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(4-ethoxy-phenyl)-ethyl]-benzamide

SMILES CCOc1ccc(C[C@@H](NC(=O)c2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)NCc2ccc(CN)cc2)cc1

InChI Key InChIKey=UCIXIQRCAGGOJY-AJQTZOPKSA-N

Data  24 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 24 hits for monomerid = 200012   

TargetPlasma kallikrein(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50:  22nMAssay Description:Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XII(Homo sapiens (Human))TBA
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human fXIIA by fluorescence based analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProthrombin(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >4.00E+4nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine protease 1(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50:  1.08E+4nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50:  3.50E+3nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XII(Homo sapiens (Human))TBA
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >4.00E+4nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine protease 1(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50:  1.08E+4nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasminogen(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50:  3.50E+3nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor X(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCoagulation factor XII [20-615](Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Human serine protease enzymes plasmin, thrombin, trypsin, Factor Xa and Factor XIIa were assayed for enzymatic activity using an appropriate fluoroge...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPlasma kallikrein(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50:  22nMAssay Description:Inhibition of plasma kallikrein (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetPlasminogen(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50:  22nMAssay Description:Inhibition of plasmin (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProthrombin(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of thrombin (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCoagulation factor XII(Homo sapiens (Human))TBA
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of fXIIa (unknown origin)More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetPlasma kallikrein(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50:  22nMAssay Description:Inhibition of human plasma kallikrein using H-DPro-Phe-Arg-AFC as substrateMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetKallikrein-1(Homo sapiens (Human))TBA
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human KLK1 using H-DVal-Leu-Arg-AFC as substrateMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetPlasminogen(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50:  3.50E+3nMAssay Description:Inhibition of human plasmin by fluorescence based analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetPlasminogen(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human plasmin by fluorescence based analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetProthrombin(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human thrombin by fluorescence based analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human trypsin by fluorescence based analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetCoagulation factor X(Homo sapiens (Human))
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human fXA by fluorescence based analysisMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetKallikrein-1(Homo sapiens (Human))TBA
LigandPNGBDBM200012(US9234000, 3 | US9512065, N-[(R)-1-[(S)-1-(4-amino...)
Affinity DataIC50: >1.00E+4nMAssay Description:KLK1 inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent